- Report
- May 2026
- 100 Pages
Global
From €5350EUR$5,950USD£4,586GBP
- Report
- April 2026
- 150 Pages
Global
From €5350EUR$5,950USD£4,586GBP
- Report
- August 2025
- 199 Pages
Global
From €3187EUR$3,545USD£2,732GBP
€3542EUR$3,939USD£3,036GBP
- Report
- August 2026
- 370 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- July 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- May 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- April 2026
- 452 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- March 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more